Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Deferred Taxes: 2022-2024

Historic Deferred Taxes for Silence Therapeutics (SLN) over the last 3 years, with Dec 2024 value amounting to $845,000.

  • Silence Therapeutics' Deferred Taxes fell 97.96% to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $384,000, marking a year-over-year change of. This contributed to the annual value of $845,000 for FY2024, which is 11.61% down from last year.
  • Silence Therapeutics' Deferred Taxes amounted to $845,000 in FY2024, which was down 11.61% from $956,000 recorded in FY2023.
  • Silence Therapeutics' 5-year Deferred Taxes high stood at $956,000 for FY2023, and its period low was $688,000 during FY2022.
  • In the last 3 years, Silence Therapeutics' Deferred Taxes had a median value of $845,000 in 2024 and averaged $829,667.
  • Per our database at Business Quant, Silence Therapeutics' Deferred Taxes surged by 38.95% in 2023 and then decreased by 11.61% in 2024.
  • Silence Therapeutics' Deferred Taxes (Yearly) stood at $688,000 in 2022, then surged by 38.95% to $956,000 in 2023, then decreased by 11.61% to $845,000 in 2024.